4-EMC
4-EMC (4-ethylmethcathinone) is a synthetic cathinone stimulant closely related to mephedrone, differing by an ethyl rather than methyl substituent on the aromatic ring. It surfaced on the research-chemical market as a legal-grey alternative to banned cathinones. Human data is essentially absent; reported effects are entirely anecdotal and describe a milder, more empathogenic and less euphoric profile than mephedrone.
01 Overview
4-EMC belongs to the ring-substituted cathinone family sold as a 'research chemical' with no approved medical use. Users report stimulation, mild mood elevation and sociability, generally weaker than mephedrone at comparable doses, which encourages compulsive redosing.
As with the whole cathinone class, the dominant hazards are compulsive redosing, cardiovascular strain, an unpleasant comedown and unknown long-term neurotoxicity. No formal pharmacokinetic or toxicological studies in humans exist, so all figures here are approximate and derived from user reports.
02 Mechanism
Acts as a releasing agent and reuptake inhibitor at dopamine, noradrenaline and serotonin transporters, with the ethyl substituent thought to shift the balance toward serotonin relative to mephedrone.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Common | 50–120 mg | Insufflated | Faster onset, stronger redose urge. |
| Common | 100–200 mg | Oral | Anecdotal; no clinical basis. |
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| StimulationIncreased energy and wakefulness reported by users. | Anecdotal | ||
| Mild empathogenesisSociability and mood lift, reported as gentler than mephedrone. | Anecdotal | ||
| Appetite suppressionReduced hunger during the active period. | Anecdotal |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Compulsive redosingStrong urge to redose as effects fade, driving binges. | Moderate | Most users | Anecdotal | |
| Cardiovascular strainRaised heart rate and blood pressure typical of the cathinone class. | Severe | Common | Unconfirmed | |
| Comedown and low moodFatigue, irritability and depressed mood after use. | Moderate | Common | Anecdotal |